Neurovalens secures £6m in funding led by Investment Fund for Northern Ireland to expand non-invasive neuro-technology

Neurovalens designs non-invasive neurostimulation devices that treat conditions such as insomnia and anxiety, using wearable technology cleared for clinical use.